Why are HPV vaccination rates so low?
National leaders and cancer center representatives recently met in Houston to review strategies for improving human papillomavirus (HPV) vaccination rates during a gathering titled Increasing HPV Vaccination in the U.S.: a Collaboration of NCI-designated Cancer Centers Summit.
The summit brought together experts from the National Cancer Institute (NCI), the American Cancer Society (ACS), the CDC and more than 35 of the nations’...
A simple answer for patients with Lynch syndrome
People with Lynch syndrome face a high risk of colorectal cancer. But researchers think that reducing this risk may be as easy as taking a...
Is the common cold the cure for cancer?
Glioblastomas, or malignant gliomas, are sometimes called “grow-and-go” tumors. They make their own blood supply, which fuels the tumors’...
Why a protein causes tumor growth in brain, but not other organs
It’s no surprise that people enjoy warm places like Hawaii, but may suffer in hostile locales such as Antarctica. A tumor suppressor gene called PTEN is similar in that it’s affected by the microenvironments of certain bodily organs to which it travels.
Scientists at MD Anderson have found that PTEN is regulated by different organs. For patients with brain metastases, this is not good, as PTEN in cells is shut off in the brain....
Experts' goal? Tweak skin cancer prevention game plan
Cancer prevention experts throughout the nation discussed new strategies for preventing skin cancer at the Texas Skin Cancer/Melanoma Screening...
A better therapy for lung cancer
An analysis of an international, cooperative-led trial of patients with locally advanced non-small cell lung cancer (NSCLC) has shown that...
The reasons why an anemia drug is hurting some patients
Scientists have shown why a drug widely used to treat chemotherapy-induced anemia in ovarian and breast cancer patients also may shorten survival...
Partnership yields new immunotherapy drug and a clinical trial
A new drug that’s based on MD Anderson research and designed to rev up an immune system assault on cancer has advanced to clinical trial both...